)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Filana Therapeutics
Filana Therapeutics (FLNA) investor relations material
Filana Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary11 Jun, 2026
Opening remarks and agenda
Meeting held virtually to increase inclusivity and accessibility for stockholders.
Business portion conducted first, followed by a Q&A session.
Forward-looking statements highlighted, with risks and uncertainties noted.
Board and executive committee updates
Introduction of board members and corporate officers, including new additions to the executive team.
Dr. Angélique Bordey and Dr. Joseph Hulihan joined as SVP of Neuroscience and Chief Medical Officer, respectively.
Strategic initiatives and plans
Focus on addressing FDA clinical hold on IND for TSC-related epilepsy program.
Extensive preclinical experiments conducted to address FDA concerns.
Collaboration with TSC Alliance and engagement with leading clinicians and trial sites.
Confidence in moving forward based on successful animal models.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Filana Therapeutics
- Net loss narrowed and expenses fell as focus shifted to TSC epilepsy, pending FDA review.FLNA
Q1 20268 May 2026 - Simufilam shows promise as a first-in-class TSC epilepsy therapy, with strong preclinical data and robust safety.FLNACorporate presentation7 May 2026
- Key votes include director elections, equity plan expansion, and auditor ratification.FLNAProxy filing28 Apr 2026
- 2025 loss widened on one-time items; focus shifts to TSC epilepsy with strong cash reserves.FLNAQ4 202512 Mar 2026
- Advancing simufilam for TSC-related epilepsy, targeting a large unmet need with strong preclinical data.FLNAInvestor presentation12 Mar 2026
- Strategic shift to TSC epilepsy, phase II-A trial in 2026, strong safety and financials.FLNAH.C. Wainwright 27th Annual Global Investment Conference3 Feb 2026
- Q2 net income $6.2M, $207.3M cash, Phase 3 trials fully enrolled, SEC reserve set.FLNAQ2 20242 Feb 2026
- Independent data validation and new leadership aim to restore confidence ahead of phase three results.FLNAH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Q3 net loss $27.9M; $149M cash; Phase 3 simufilam data due by end of 2024.FLNAQ3 202416 Jan 2026
Next Filana Therapeutics earnings date
Q2 20266 Aug, 2026
Filana Therapeutics
Next Filana Therapeutics earnings date
Q2 20266 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage